Europe Vitreoretinal Surgery Devices Market by Types (Photocoagulation Devices, Vitrectomy Surgery Devices, Ilumination Surgery Devices), by End-Users (Private Eye clinics, and Hospitals) – Analysis and Forecast to 2019

The demand for vitreoretinal surgeries has increased significantly from 2014 to 2019, mainly due to rising incidents of eye diseases. Vitreoretinal surgery devices are used in the treatment of detached eye retinas. The retina is a crucial and extremely sensitive part of the human eye and is made up of various tissue layers. These tissue layers can be damaged due to various factors, including age-related damage, muscular holes, or severe eye injuries. In accordance with a study conducted by PubMed, it has been found that retinal detachment comprises nearly 5.8% of the total number of cases of vitreoretinal diseases. Vitreoretinal diseases are found to be more common in male patients aged 40 years and above, and the growing aging population have resulted in increased prevalence of eye diseases.

The European Vitreoretinal surgery device market is segmented into various sub-types like photocoagulation, vitrectomy, and illumination devices. Out of its sub-types, photocoagulation type holds the highest market share of 52.8%, followed by vitrectomy covering a market share of 34.8% of the global market.

The European vitreoretinal surgery device market is estimated to grow at a CAGR of 13.5 % during the forecast period of 2014 to 2019. Various technological advancements in the medical field, increasing aging population and rise in the number of retinopathies have created growing opportunities in the market.

In-depth market share analysis, by revenue of the top companies is included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports and interviews with industry experts, key opinion leaders such as CEOs, directors, and marketing executives. Detailed market share analysis of the major players in the European vitreoretinal surgery devices market is covered in this report.

The key players in the European vitreoretinal surgery devices market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), and Nidek Co., Ltd. (U.S)

Table of Contents

1 Introduction (Page No. - 9)
    1.1 Objectives of the Study
    1.2 Market Segmentation & Coverage
    1.3 Stakeholders

2 Research Methodology (Page No. - 11)
    2.1 Integrated Ecosystem of Vitreoretinal Surgery Devices Market
           2.1.1 Top-Down Approach
           2.1.2 Bottom-Up Approach
           2.1.3 Demand Side Approach
           2.1.4 Macro Indicator-Based Approach
    2.2 Assumptions

3 Executive Summary (Page No. - 18)

4 Market Overview (Page No. - 19)
    4.1 Introduction
    4.2 Europe Vitreoretinal Surgery Devices : Comparison With Parent Market
    4.3 Market Drivers and Inhibitors
    4.4 Key Market Dynamics
    4.5 Demand Side Analysis

5 Europe Vitreoretinal Surgery Devices Market, By End-User (Page No. - 26)
    5.1 Introduction
    5.2 Europe Vitreoretinal Surgery Devices Market in Private Eye Clinics,  By Geography
    5.3 Europe Vitreoretinal Surgery Devices Market in Hospitals,  By Geography

6 Europe Vitreoretinal Surgery Devices Market, By Type (Page No. - 30)
    6.1 Introduction
    6.2 Europe : Vitreoretinal Surgery Devices Market, Type Comparison With Ophthalmology Surgery Devices Market
    6.3 Europe : Photocoagulation Vitreoretinal Surgery Devices Market,  By Geography
    6.4 Europe : Vitrectomy Vitreoretinal Surgery Devices Market,  By Geography
    6.5 Europe : Illumination Vitreoretinal Surgery Devices Market,  By Geography

7 Europe Vitreoretinal Surgery Devices Market, By Geography (Page No. - 36)
    7.1 Introduction
    7.2 Germany : Vitreoretinal Surgery Devices Market
           7.2.1 Germany : Vitreoretinal Surgery Devices Market, By End-Users
           7.2.2 Germany : Vitreoretinal Surgery Devices Market, By Type
    7.3 France : Vitreoretinal Surgery Devices Market
           7.3.1 France : Vitreoretinal Surgery Devices Market, By End-Users
           7.3.2 France : Vitreoretinal Surgery Devices Market, By Type
    7.4 U.K. : Vitreoretinal Surgery Devices Market
           7.4.1 U.K.: Vitreoretinal Surgery Devices Market, By End-Users
           7.4.2 U.K.: Vitreoretinal Surgery Devices Market, By Type
    7.5 Italy : Vitreoretinal Surgery Devices Market
           7.5.1 Italy : Vitreoretinal Surgery Devices Market, By End-Users
           7.5.2 Italy : Vitreoretinal Surgery Devices Market, By Type
    7.6 Spain : Vitreoretinal Surgery Devices Market
           7.6.1 Spain: Vitreoretinal Surgery Devices Market, By End-Users
           7.6.2 Spain : Vitreoretinal Surgery Devices Market, By Type

8 Europe Vitreoretinal Surgery Devices Market: Competitive Landscape (Page No. - 56)
    8.1 Europe Vitreoretinal Surgery Devices Market: Company Share Analysis
    8.2 Mergers & Acquisitions
    8.3 Agreements/Partnerships/Collaborations
    8.4 New Technology/Product Development

9 Europe Vitreoretinal Surgery Devices Market, By Company (Page No. - 60)
(Overview, Financials, Products & Services, Strategy, and Developments)*
    9.1 Abbott Laboratories
    9.2 Alcon, Inc.
    9.3 Allergan, Inc.
    9.4 Baush & Lomb, Inc.
    9.5 Carl Zeiss Meditech AG
    9.6 Essilor Internationals S.A.
    9.7 Nidek Co., Limited
    9.8 Topcon Corporation
*Details On Overview, Financials, Product & Services, Strategy, and Developments Might Not Be Captured in Case of Unlisted Company

10 Appendix (Page No. - 79)
     10.1 Customization Options
             10.1.1 Product Analysis
             10.1.2 Surgeons/Physicians Perception Analysis
             10.1.3 Brand/Product Perception Matrix
             10.1.4 Impact Analysis
             10.1.5 Porter’s Five Forces Analysis
     10.2 Related Reports
     10.3 Introducing RT: Real Time Market Intelligence
             10.3.1 RT Snapshots

List of Tables (34 Tables)

Table 1 Vitreoretinal Application Market for Aging Population, 2014 (BN)
Table 2 Vitreoretinal Surgery Devices Market: Macroindicators,  By Geography, 2014
Table 3 Vitreoretinal Market: Comparison With Parent Market,  2013–2019 (USD MN)
Table 4 Vitreoretinal Surgery Devices Market: Drivers and Inhibitors
Table 5 Europe : Vitreoretinal Surgery Devices Market, By End-User 2013–2019 (USD MN)
Table 6 Europe :Vitreoretinal Surgery Devices Market, By Type,  2013–2019 (USD MN)
Table 7 Europe: Vitreoretinal Surgery Devices Market, By Geography,  2013–2019 (USD MN)
Table 8 Europe Vitreoretinal Surgery Devices Market: Comparison With End–User Markets, 2013–2019 (USD MN)
Table 9 Europe: Vitreoretinal Surgery Device Market, By End-User,  2013–2019 (USD MN)
Table 10 Europe Vitreoretinal Surgery Devices Market in Private Eye Clinics,  By Geography, 2013–2019 (USD MN)
Table 11 Europe Vitreoretinal Surgery Devices Market in Hospitals, By Geography, 2013–2019 (USD MN)
Table 12 Europe : Vitreoretinal Surgery Devices Market, By Type,  2013–2019 (USD MN)
Table 13 Vitreoretinal Surgery Devices Market: Type Comparison With Parent Market, 2013–2019 (USD MN)
Table 14 Europe : Photocoagulation Vitreoretinal Surgery Devices Market,  By Geography, 2013–2019 (USD MN)
Table 15 Europe: Vitrectomy Vitreoretinal Surgery Devices Market,  By Geography, 2013–2019 (USD MN)
Table 16 Europe : Illumination Vitreoretinal Surgery Devices Market,  By Geography, 2013–2019 (USD MN)
Table 17 Europe : Vitreoretinal Surgery Devices Market, By Geography,  2013–2019 (USD MN)
Table 18 Germany : Vitreoretinal Surgery Devices Market, By,  2013-2019 (USD MN)
Table 19 Germany : Vitreoretinal Surgery Devices Market, By Type,  2013–2019 (USD MN)
Table 20 France : Vitreoretinal Surgery Devices Market, By End-Users,  2013–2019 (USD MN)
Table 21 France : Vitreoretinal Surgery Devices Market, By Type,  2013–2019 (USD MN)
Table 22 U.K. : Vitreoretinal Surgery Devices Market, By End-Users,  2013–2019 (USD MN)
Table 23 U.K. : Vitreoretinal Surgery Devices Market, By Type, 2013–2019 (USD MN)
Table 24 Italy : Vitreoretinal Surgery Devices Market, By End-Users,  2013–2019 (USD MN)
Table 25 Italy : Vitreoretinal Surgery Devices Market, By Type,  2013–2019 (USD MN)
Table 26 Spain : Vitreoretinal Surgery Devices Market, By 2013–2019 (USD MN)
Table 27 Spain : Vitreoretinal Surgery Devices Market, By Type,  2013–2019 (USD MN)
Table 28 Europe Vitreoretinal Surgery Devices Market: Company Share Analysis, 2014 (%)
Table 29 Europe Vitreoretinal Surgery Devices Market: Mergers & Acquisitions
Table 30 Europe Vitreoretinal Surgery Devices Market: Collaborations
Table 31 Europe Ophthalmology Surgery Devices Market: New Technology/Product Development
Table 32 Abbott Laboratories: Key Financials, 2009-2013 (USD MN)
Table 33 Allergan, Inc.: Key Operations Data, 2009-2013 (USD MN)
Table 34 Essilor Internationals S.A Key Financials, 2008-2013 (USD MN)

List of Figures (44 Figures)

Figure 1 Europe : Vitreoretinal Market: Segmentation & Coverage
Figure 2 Vitreoretinal Surgery Devices Market: Integrated Ecosystem
Figure 3 Top-Down Approach
Figure 4 Bottom-Up Approach
Figure 5 Demand Side Approach
Figure 6 Macro Indicator-Based Approach
Figure 7 Vitreoretinal Surgery Devices Market Snapshot
Figure 8 Vitreoretinal Surgery Devices Market: Growth Aspects
Figure 9 Europe : Vitreoretinal Surgery Devices Market, By Application,  2014 & 2019
Figure 10 Europe : Vitreoretinal Surgery Devices Market, By Geography,  2014 (USD MN)
Figure 11 Europe : Vitreoretinal Surgery Devices Market, By End-User,  2014-2019 (USD MN)
Figure 12 Europe Vitreoretinal Surgery Devices Market in Private Eye Clinics,  By Geography, 2013–2019 (USD MN)
Figure 13 Europe Vitreoretinal Surgery Devices Market in Hospitals,  By Geography, 2013–2019 (USD MN)
Figure 14 Europe : Vitreoretinal Surgery Devices Market, By Type,  2013–2019 (USD MN)
Figure 15 Europe : Vitreoretinal Surgery Devices Market: Type Comparison With Ophthalmology Surgery Devices Market, 2013–2019 (USD MN)
Figure 16 Europe: Photocoagulation Vitreoretinal Surgery Devices Market, 2013–2019 (USD MN)
Figure 17 Europe: Vitrectomy Vitreoretinal Surgery Devices Market,  By Geography, 2013–2019 (USD MN)
Figure 18 Europe : Illumination Vitreoretinal Surgery Devices Market,  By Geography, 2013–2019 (USD MN)
Figure 19 Germany: Vitreoretinal Surgery Devices Market Overview,  2014 & 2019 (%)
Figure 20 Germany : Vitreoretinal Surgery Devices Market, By End-Users,  2013-2019 (USD MN)
Figure 21 Germany : Vitreoretinal Surgery Devices Market, By Application: Application Snapshot
Figure 22 Germany : Vitreoretinal Surgery Devices Market, By Type,  2013–2019 (USD MN)
Figure 23 Germany: Vitreoretinal Surgery Devices Market: Market Share, By Type, 2014-2019 (%)
Figure 24 France: Vitreoretinal Surgery Devices Market, Overview,  2014 & 2019 (%)
Figure 25 France : Vitreoretinal Surgery Devices Market, By End-Users,  2013-2019 (USD MN)
Figure 26 France : Vitreoretinal Surgery Devices Market: Application Snapshot
Figure 27 France : Vitreoretinal Surgery Devices Market, By Type,  2013–2019 (USD MN)
Figure 28 France : Vitreoretinal Surgery Devices Market Share, By Type,  2014-2019 (%)
Figure 29 U.K. : Vitreoretinal Surgery Devices Market Overview, 2014 & 2019 (%)
Figure 30 U.K. : Vitreoretinal Surgery Devices Market, By End-Users,  2013-2019 (USD MN)
Figure 31 U.K. : Vitreoretinal Surgery Devices Market: Application Snapshot
Figure 32 U.K. : Vitreoretinal Surgery Devices Market, By Type, 2013–2019 (USD MN)
Figure 33 U.K. : Vitreoretinal Surgery Devices Market: Type Snapshot
Figure 34 Italy : Vitreoretinal Surgery Devices Market Overview, 2014 & 2019 (%)
Figure 35 Italy : Vitreoretinal Surgery Devices Market, By End-Users,  2013- 2019 (USD MN)
Figure 36 Italy : Vitreoretinal Surgery Devices Market: Application Snapshot
Figure 37 Italy : Vitreoretinal Surgery Devices Market, By Type,  2013–2019 (USD MN)
Figure 38 Italy : Vitreoretinal Surgery Devices Market: Type Snapshot
Figure 39 Spain : Vitreoretinal Surgery Devices Market Overview, 2014 & 2019 (%)
Figure 40 Spain : Vitreoretinal Surgery Devices Market, By End-Users, 2013-2019 (USD MN)
Figure 41 Spain : Vitreoretinal Surgery Devices Market Snapshot
Figure 42 Spain : Vitreoretinal Surgery Devices Market, By Type,  2013–2019 (USD MN)
Figure 43 Spain : Vitreoretinal Surgery Devices Market: Type Snapshot
Figure 44 Europe : Vitreoretinal Surgery Devices Market: Company Share Analysis, 2014(%)

Vitreoretinal surgery devices are used in the treatment of detached eye retinas. The retina is a crucial and extremely sensitive part of the human eye and is made up of various tissue layers. These tissue layers can be damaged due to various factors, including age-related damage, muscular tears, or severe eye injuries. In accordance with a study conducted by PubMed, it has been found that retinal detachment comprises nearly 5.8% of the total number of cases of vitreoretinal diseases. Moreover, since vitreoretinal diseases are found to be more common in male patients aged 40 years and above, the growing aging population has resulted in an increase in prevalence of these diseases.

Vitreoretinal has continued to remain robust across all regions. This is because the constantly rising diseases associated with eyes in recent years have encouraged the growth of the market. Income has made treatment more affordable. Also there is rise in the geriatric population as well as increase in the number of retinopathies.

The European Vitreoretinal devices market, by type, was valued at $206.9 million in 2014 and is projected to reach $389.9 million by 2019 at a CAGR of 13.5 % during the forecast period of 2014 to 2019. The market was led by photocoagulation in 2014, with a 52.8 % share. It is projected to reach a value of $ 194.4 million at a CAGR of 12.2 % through the forecast period. The illumination devices market is estimated to grow at the highest CAGR of 14.6% through 2019. Europe is a key market for vitreoretinal surgery devices. The aging population has been a major segment in terms of application in 2014. Private eye clinics have been the major end-users for this market in 2014.

European Vitreoretinal Surgery Device market is further segmented and forecast on the basis of major countries such as Germany, France, the U.K., Italy, Spain and RoE. Amongst all, Germany accounted for the largest share of 25.4% in the year 2014, with the revenue of $88.9 million, at a CAGR of 9.9% in the forecast period of 2014-2019.

The key players in the European Vitreoretinal market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), and Nidek Co.